The impact of RJ on AMPK expression and its related transcription factors will be assessed in the presence or absence of an AMPK inhibitor to elucidate the underlying mechanisms of its anti-obesity effects. The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.